Chan Danny
Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK.
IDrugs. 2010 Nov;13(11):749-52.
The XXIst International Symposium on Medicinal Chemistry from the European Federation of Medicinal Chemistry (EFMC-ISMC), held in Brussels, included topics covering new therapeutic developments in the field of medicinal research. This conference report highlights selected presentations on therapies for neuropathic pain, cognitive disorders, cancer and infection. Investigational drugs discussed include the anticancer imidazole derivative IRC-083927 (Ipsen), the HCV protease inhibitor TMC-435 (Tibotec Pharmaceuticals) and the tuberculosis therapy bedaquiline (Tibotec Pharmaceuticals).
由欧洲药物化学联合会（EFMC-ISMC）举办的第21届国际药物化学研讨会在布鲁塞尔召开，会议主题涵盖药物研究领域的新治疗进展。本会议报告重点介绍了关于神经性疼痛、认知障碍、癌症和感染治疗的部分演讲内容。所讨论的研究性药物包括抗癌咪唑衍生物IRC-083927（益普生公司）、丙型肝炎病毒蛋白酶抑制剂TMC-435（蒂博泰克制药公司）以及结核病治疗药物贝达喹啉（蒂博泰克制药公司）。
